Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment

J Gutierrez, TN Turan, BL Hoh… - The Lancet Neurology, 2022 - thelancet.com
Intracranial atherosclerotic stenosis (ICAS) is one of the most frequent causes of stroke
worldwide and confers one of the greatest risks of recurrent stroke compared with other …

Stroke in China: advances and challenges in epidemiology, prevention, and management

S Wu, BO Wu, M Liu, Z Chen, W Wang… - The Lancet …, 2019 - thelancet.com
With over 2 million new cases annually, stroke is associated with the highest disability-
adjusted life-years lost of any disease in China. The burden is expected to increase further …

[HTML][HTML] Trial of endovascular therapy for acute ischemic stroke with large infarct

X Huo, G Ma, X Tong, X Zhang, Y Pan… - … England Journal of …, 2023 - Mass Medical Soc
Background The role of endovascular therapy for acute stroke with a large infarction has not
been extensively studied in differing populations. Methods We conducted a multicenter …

Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS …

P Gao, T Wang, D Wang, DS Liebeskind, H Shi, T Li… - Jama, 2022 - jamanetwork.com
Importance Prior randomized trials have generally shown harm or no benefit of stenting
added to medical therapy for patients with symptomatic severe intracranial atherosclerotic …

Reteplase versus Alteplase for Acute ischemic stroke

S Li, HQ Gu, H Li, X Wang, A Jin, S Guo… - … England Journal of …, 2024 - Mass Medical Soc
Background Alteplase is the standard agent used in early reperfusion therapy, but
alternative thrombolytic agents are needed. The efficacy and safety of reteplase as …

Extracranial-intracranial bypass and risk of stroke and death in patients with symptomatic artery occlusion: the CMOSS randomized clinical trial

Y Ma, T Wang, H Wang, S Amin-Hanjani, X Tong… - Jama, 2023 - jamanetwork.com
Importance Prior trials of extracranial-intracranial (EC-IC) bypass surgery showed no benefit
for stroke prevention in patients with atherosclerotic occlusion of the internal carotid artery …

Comparison of drug-eluting stent with bare-metal stent in patients with symptomatic high-grade intracranial atherosclerotic stenosis: a randomized clinical trial

B Jia, X Zhang, N Ma, D Mo, F Gao, X Sun… - JAMA …, 2022 - jamanetwork.com
Importance In-stent restenosis (ISR) is the primary reason for stroke recurrence after
intracranial stenting in patients who were treated with a standard bare-metal stent (BMS) …

Large vessel occlusion stroke due to intracranial atherosclerotic disease: identification, medical and interventional treatment, and outcomes

A De Havenon, OO Zaidat, S Amin-Hanjani… - Stroke, 2023 - Am Heart Assoc
Large vessel occlusion stroke due to underlying intracranial atherosclerotic disease (ICAD-
LVO) is prevalent in 10 to 30% of LVOs depending on patient factors such as vascular risk …

Remote ischaemic conditioning—a new paradigm of self-protection in the brain

DC Hess, RA Blauenfeldt, G Andersen… - Nature Reviews …, 2015 - nature.com
Remote ischaemic conditioning (RIC) triggers endogenous protective pathways in distant
organs such as the kidney, heart and brain, and represents an exciting new paradigm in …

Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of CHANCE

L Liu, KSL Wong, X Leng, Y Pu, Y Wang, J Jing, X Zou… - Neurology, 2015 - AAN Enterprises
Objective: We aimed to investigate whether the efficacy and safety of clopidogrel plus aspirin
vs aspirin alone were consistent between patients with and without intracranial arterial …